NEWS - Sep 28, 2016 Relmada Therapeutics' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston Read more
NEWS - Sep 22, 2016 Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference Read more
NEWS - Sep 14, 2016 Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern Read more
NEWS - Sep 12, 2016 Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team Read more
NEWS - Sep 7, 2016 Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference Read more
NEWS - Jun 27, 2016 Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression Read more
NEWS - Jun 7, 2016 Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia Read more
